Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Inventory (2016 - 2025)

Mesa Laboratories' Inventory history spans 15 years, with the latest figure at $26.6 million for Q4 2025.

  • For Q4 2025, Inventory rose 4.71% year-over-year to $26.6 million; the TTM value through Dec 2025 reached $26.6 million, up 4.71%, while the annual FY2025 figure was $25.4 million, 22.37% down from the prior year.
  • Inventory for Q4 2025 was $26.6 million at Mesa Laboratories, down from $27.7 million in the prior quarter.
  • Across five years, Inventory topped out at $34.6 million in Q1 2023 and bottomed at $11.2 million in Q1 2021.
  • The 5-year median for Inventory is $26.7 million (2022), against an average of $26.2 million.
  • The largest annual shift saw Inventory surged 120.13% in 2022 before it decreased 22.37% in 2025.
  • A 5-year view of Inventory shows it stood at $23.7 million in 2021, then surged by 42.24% to $33.7 million in 2022, then increased by 2.68% to $34.6 million in 2023, then dropped by 26.78% to $25.4 million in 2024, then increased by 4.71% to $26.6 million in 2025.
  • Per Business Quant, the three most recent readings for MLAB's Inventory are $26.6 million (Q4 2025), $27.7 million (Q3 2025), and $28.1 million (Q2 2025).